Advair Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Therapeutic Equivalence of Two Formulations of Fluticasone Propionate and Salmeterol Inhalation Powder in Subjects With Asthma
Condition: Asthma Interventions: Drug: Fluticasone Propionate and Salmeterol Inhalation Powder; Drug: Placebo Inhalation Powder Sponsors: Actavis Inc.; Teva Pharmaceuticals USA Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 28, 2018 Category: Research Source Type: clinical trials

Salmeterol/Fluticasone Easyhaler in the Treatment of Asthma and COPD
Conditions: Asthma; Chronic Obstructive Pulmonary Disease Intervention: Sponsor: Orion Corporation, Orion Pharma Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 28, 2018 Category: Research Source Type: clinical trials

A Bioequivalence Study Between Fluticasone Salmeterol Xinafoate vs. ADVAIR DISKUS ® in Healthy Volunteers
Condition: Bioequivalence Interventions: Drug: Fluticasone propionate 500 mcg and salmeterol xinafoate 50 mcg; Drug: ADVAIR DISKUS Sponsors: Respirent Pharmaceuticals Co Ltd.; BECRO Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2018 Category: Research Source Type: clinical trials

A Bioequivalence Study Between Fluticasone Salmeterol Xinafoate vs. ADVAIR DISKUS ® in Healthy Volunteers
Condition: Bioequivalence Interventions: Drug: Fluticasone propionate 500 mcg and salmeterol xinafoate 50 mcg; Drug: ADVAIR DISKUS Sponsors: Respirent Pharmaceuticals Co Ltd.; BECRO Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2018 Category: Research Source Type: clinical trials